93 related articles for article (PubMed ID: 25802447)
41. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN
Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
43. [E.coli from urinary tract infections and acute pyelonephritis of children: 1% of strains are resistant to a subset of third generation cephalosporins].
Prère MF; Licznar P; Decramer S; Fayet O
Pathol Biol (Paris); 2004 Oct; 52(8):497-500. PubMed ID: 15465272
[TBL] [Abstract][Full Text] [Related]
44. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
Briales A; Rodríguez-Martínez JM; Velasco C; de Alba PD; Rodríguez-Baño J; Martínez-Martínez L; Pascual A
Int J Antimicrob Agents; 2012 May; 39(5):431-4. PubMed ID: 22365240
[TBL] [Abstract][Full Text] [Related]
46. Levofloxacin for the treatment of pyelonephritis.
Rafat C; Debrix I; Hertig A
Expert Opin Pharmacother; 2013 Jun; 14(9):1241-53. PubMed ID: 23614756
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
48. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
49. Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis.
Ha YE; Kang CI; Joo EJ; Park SY; Kang SJ; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Scand J Infect Dis; 2011 Aug; 43(8):587-95. PubMed ID: 21453206
[TBL] [Abstract][Full Text] [Related]
50. [Bacteriologic diagnosis and antibiotic therapy of urinary tract infections].
Caron F
Rev Prat; 2003 Oct; 53(16):1760-9. PubMed ID: 14702817
[TBL] [Abstract][Full Text] [Related]
51. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
Oktem IM; Gulay Z; Bicmen M; Gur D;
Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
[TBL] [Abstract][Full Text] [Related]
52. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
53. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
Kader AA; Angamuthu K
Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
[TBL] [Abstract][Full Text] [Related]
54. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Ma J; Zeng Z; Chen Z; Xu X; Wang X; Deng Y; Lü D; Huang L; Zhang Y; Liu J; Wang M
Antimicrob Agents Chemother; 2009 Feb; 53(2):519-24. PubMed ID: 18936192
[TBL] [Abstract][Full Text] [Related]
55. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
56. A Way to Prеdict an Imminеnt Cardiac Arrеst on Abdominal CT Scan: About a Casе.
Audi P; Menassa-Moussa L; Smayra T; Aoun N
Case Rep Oncol; 2019; 12(3):796-801. PubMed ID: 31762751
[TBL] [Abstract][Full Text] [Related]
57. Microbiological Spectrum and Outcomes of Acute Pyelonephritis in North Indian Population.
Hase AN; Bansal SB; Gadde AB; Nandwani A
Saudi J Kidney Dis Transpl; 2021; 32(1):209-217. PubMed ID: 34145133
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of chitosan and silver nanoparticles Against isolated pathogens from Mulberry Silkworm, Bombyx mori L. (Lepidoptera: Bombycidae) under laboratory conditions.
El-Adly AM; Saba RM; Laban GFA; Mahmoud MA; Elsaffany AH; AbdElrahman IE
Braz J Biol; 2022; 82():e264903. PubMed ID: 36228288
[TBL] [Abstract][Full Text] [Related]
59. [Antibacterial therapy of patients with urolithiasis: efficacy and safety].
Zheglova ES; Babak SV; Novikov AI
Antibiot Khimioter; 2009; 54(9-10):48-52. PubMed ID: 20415265
[TBL] [Abstract][Full Text] [Related]
60. [The validation of empirical emergency antibacterial therapy in acute pyelonephritis].
Mitchenko MV
Lik Sprava; 1996; (10-12):94-7. PubMed ID: 9138828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
